Prognostic capacity of D-dimer in predicting mortality in patients diagnosed with COVID-19

Joseph Alburqueque Melgarejo,,Israel Armando Guerra Cuyutupac,Juan Carlos Ezequiel Roque Quezada,Horus Michael Virú Flores,Martha Eugenia Aguirre Coronado,Luis Enrique Nieves Cordova,,,,,,
DOI: https://doi.org/10.25176/rfmh.v24i2.6558
2024-04-29
Revista de la Facultad de Medicina Humana
Abstract:Introduction: SARS-CoV-2 infection can increase the risk of thrombosis. Studies associate D-dimer levels with COVID-19 mortality. Objective: To determine the prognostic capacity of D-dimer in predicting COVID-19 mortality in patients hospitalized in the Intensive Care Unit. Methods: A retrospective cohort study was conducted at the Centro Médico Naval from January to July 2021. A total of 324 adult patients with RT-PCR confirmed COVID-19 were included. D-dimer levels were measured upon admission using coagulation turbidimetry (Sysmex CS-5100). Sociodemographic variables, comorbidities, and clinical data were analyzed. Statistical analysis was performed using SPSS version 26, employing Chi-square tests, Fisher's exact test, Mann-Whitney U test, ROC, and Cox regression. Results: A cut-off point of 1.40 μg/mL for D-dimer values was determined, with a sensitivity of 80.9%, specificity of 86.4%, and an area under the curve (AUC) of 0.916 (95% CI: 0.884 – 0.947; p=0.016) for predicting COVID-19 mortality. Additionally, patients with D-dimer values greater than or equal to 1.40 μg/mL had an increased risk of death (adjusted HR = 6.545; 95% CI: 3.867 – 11.077; p<0.001), independent of age, diabetes mellitus, arterial hypertension, ischemic heart disease, cerebrovascular disease, atrial fibrillation, chronic obstructive pulmonary disease, asthma, cancer, and thrombocytopenia. Conclusion: This study showed that admission D-dimer levels represent a reliable biomarker in evaluating the prognosis of COVID-19 patients.
What problem does this paper attempt to address?